Ameliorative Effect of Banana Lectin in TNBS-Induced Colitis in C57BL/6 Mice Relies on the Promotion of Antioxidative Mechanisms in the Colon
Biomolecules · 2025
DOI: 10.3390/biom15040476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Radmila Miljković und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, Institute of Virology, Vaccines and Sera "Torlak", 11221 Belgrade, Serbia. Hauptthemen laut MEDLINE: Colitis, Musa, Colon, Antioxidants. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation, Serbia, Ministry of Science, Technological Development and Innovation, Republic of Serbia.
Abstract (Originalsprache)
Background
The global burden of inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn’s disease, is constantly rising. As IBDs significantly reduce patients’ quality of life, prevention and efficient treatment of IBDs are of paramount importance. Although the molecular mechanisms underlying IBD pathogenesis are still not completely understood, numerous studies indicate the essential role of oxidative stress in the progression of the diseases.
Objective
The aim of this study was to investigate whether prophylactic administration of recombinant banana lectin (rBanLec) could positively affect antioxidative mechanisms in the colon and thus prevent or alleviate the severity of experimental colitis induced in C57BL/6 mice.
Methods
The prophylactic potential of rBanLec, a mannose-binding lectin with immunomodulatory properties, was investigated in a model of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in C57BL/6 mice. Mice received rBanLec at various doses (0.1, 1 and 10 μg/mL) before the induction of colitis. The severity of the disease was assessed by weight loss and reduction in colon length, and correlated with histopathological findings, cytokine milieu, and oxidative stress markers in the colon.
Results
The obtained results revealed that pretreatment with a low dose of rBanLec (0.1 μg/mL) significantly reduced the severity of TNBS-induced colitis, as indicated by reduced weight loss, less severe histopathological damage, and a favorable anti-inflammatory cytokine milieu (increased IL-10 and TGFβ). In addition, rBanLec pretreatment improved the activity of antioxidant enzymes (SOD, CAT, and GST) and reduced markers of oxidative stress such as nitric oxide levels at the peak of the disease. In contrast, higher doses of rBanLec exacerbated inflammatory responses.
Conclusions
Our findings indicate that at low doses rBanLec can alleviate the severity of colitis by modulating oxidative stress and promoting anti-inflammatory cytokine responses, positioning rBanLec as a potential candidate for treating IBDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Research and Development, Institute of Virology, Vaccines and Sera "Torlak", 11221 Belgrade, Serbia.
- Institute for Immunology, University Hospital Heidelberg, 69120 Heidelberg, Germany.
- Department of Biochemistry, Faculty of Chemistry, University of Belgrade, 11158 Belgrade, Serbia.
- Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.
- Department of Molecular Biology, Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade, 11108 Belgrade, Serbia.
ORCID-Profile: Radmila Miljković, Emilija Marinković, Ivana Prodić, Isidora Protić-Rosić, Marko Vasić, Ivana Lukić, Marija Gavrović-Jankulović, Marijana Stojanović
Förderung
- Ministry of Science, Technological Development and Innovation, Serbia
- Ministry of Science, Technological Development and Innovation, Republic of Serbia
Zitieren
APA
Miljković, R., Marinković, E., Prodić, I., Kovačević, A., Protić-Rosić, I., Vasić, M., Lukić, I., Gavrović-Jankulović, M., & Stojanović, M. (2025). Ameliorative Effect of Banana Lectin in TNBS-Induced Colitis in C57BL/6 Mice Relies on the Promotion of Antioxidative Mechanisms in the Colon. Biomolecules. https://doi.org/10.3390/biom15040476
Vancouver
Miljković R, Marinković E, Prodić I, Kovačević A, Protić-Rosić I, Vasić M, et al. Ameliorative Effect of Banana Lectin in TNBS-Induced Colitis in C57BL/6 Mice Relies on the Promotion of Antioxidative Mechanisms in the Colon. Biomolecules. 2025. doi:10.3390/biom15040476
BibTeX
@article{Miljkovi2025,
author = {Miljković, Radmila and Marinković, Emilija and Prodić, Ivana and Kovačević, Ana and Protić-Rosić, Isidora and Vasić, Marko and Lukić, Ivana and Gavrović-Jankulović, Marija and Stojanović, Marijana},
title = {Ameliorative Effect of Banana Lectin in TNBS-Induced Colitis in C57BL/6 Mice Relies on the Promotion of Antioxidative Mechanisms in the Colon},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15040476}
}
EUVIMED